Poor and insufficient sleep creates heart problems: what we know from research

Initial note. This article was previously published and has been updated according to rigorous scientific and informative criteria. Its purpose is informational: it does not replace medical advice or individual clinical evaluation.

In brief

• Several observational studies indicate that very short or very long sleep duration and poor sleep quality are associated with an increased risk of cardiovascular events.
• Research suggests that sleeping an average of around 7–8 hours is linked to the lowest risk; excesses or deficiencies show a U- or J-shaped relationship.
• Sleep can influence blood pressure, metabolism, inflammation, and autonomic rhythm: these are plausible mechanisms linking sleep and the cardiovascular system.
• The main evidence comes from observational studies: they are robust for associations but limited in defining direct causality.

Abstract: what does science say?

Definition: the term “sufficient sleep” refers here to a sleep duration and quality that allows one to wake up rested; many studies use 7 hours per night as a reference for the adult population. Available evidence: vast cohorts and meta-analyses show associations between sleep duration/quality and the risk of cardiovascular diseases and mortality, often with U-shaped patterns (higher risk for very short and very long sleep). Dose and context dependence: the effect varies with the measure of sleep (self-reported vs. objective), age, presence of obstructive sleep apnea, and other risk factors. Interpretive limitations: most evidence is observational, susceptible to confounding and possible reverse causality (underlying disease altering sleep). In terms of public health, sleep emerges as an additional component to traditional lifestyle factors but requires prudent interpretation.

Key epidemiological evidence

A large-scale prospective study conducted in the Netherlands (MORGEN) showed that adding sufficient sleep duration (≥7 hours) to the four traditional lifestyle factors (physical activity, healthy diet, moderate alcohol consumption, and not smoking) was associated with a further reduction in the risk of cardiovascular diseases compared to the four traditional factors alone; the study coordinator was W. M. Monique Verschuren [1].

Meta-analyses and systematic reviews of millions of participants have documented a non-linear relationship between sleep hours and cardiovascular risk: both very short and very long sleep often result in increased risks, with the minimum risk generally located around 7–8 hours per night [2][3][5].

Studies tracking sleep patterns over time show that persistent patterns of very short or variable sleep are linked to an increased risk of cardiovascular events and mortality [4].

Measures and results: what studies evaluate

Research uses different measures: self-reported questionnaires, clinical event registries, instrumental examinations for subclinical atherosclerosis, and, in some cases, objective monitoring (actigraphy). This variability partly explains the differences between studies. Meta-analyses integrating many cohorts provide an overview, but the results must be read taking into account the different methodologies [2][5][6].

Plausible biological mechanisms

The link between sleep and cardiovascular health is supported by plausible physiological mechanisms. Chronic sleep deprivation increases sympathetic activation, alters nocturnal and diurnal blood pressure control, and can increase levels of inflammatory markers (e.g., interleukins and CRP). Furthermore, sleep deprivation influences glucose metabolism, insulin sensitivity, and appetite-regulating hormones, factors that promote obesity, diabetes, and hypertension — all recognized cardiovascular risk factors [9][8].

Sleep quality vs. sleep duration

In addition to duration, sleep quality (night awakenings, sleep efficiency, daytime sleepiness) is independently associated with coronary events in some analyses. Some studies indicate that individuals with short but good quality sleep may have lower risks than those who sleep more hours but with poor efficiency [3][7].

What reviews and meta-analyses show

Systematic reviews and meta-analyses on large populations confirm a recurring pattern: a U-shaped relationship between sleep duration and the risk of coronary heart disease, stroke, and cardiovascular mortality. Some analyses suggest that the risk increases more sharply for excessive sleep than for slightly reduced sleep; other evidence indicates that marked deficiency (e.g., <6 hours) is associated with an increased risk of cardiac events [2][3][5].

It is important to note that differences between subjective and objective measures can influence the estimation of the association: self-reported sleep tends to overestimate duration compared to actigraphy or polysomnography, with possible effects on aggregated results [2][5].

What it means in practice

For the reader: the evidence suggests that sleep is an integral part of the determinants of cardiovascular status but is not an isolated factor. Regularly sleeping around 7–8 hours per night and having good sleep quality is associated with more favorable risk profiles; however, these associations derive mainly from observational studies and do not authorize individual clinical recommendations without medical evaluation. In people with symptoms attributable to sleep disorders (persistent insomnia, excessive daytime sleepiness, loud snoring, or breathing pauses), it is appropriate to consult a doctor: obstructive sleep apnea, for example, is a diagnosable and treatable condition that affects cardiovascular risk [8].

For the general public, thinking of sleep as an additional element — along with diet, physical activity, weight control, and not smoking — is consistent with the literature: improving sleep regularity and quality can be part of an overall health strategy, while remembering that the evidence does not definitively prove that increasing sleep hours alone reduces heart attacks in all cases [1][3][5].

Key takeaways

• Sleep duration and quality are correlated with cardiovascular risk in numerous observational studies.
• The lowest risk profile in the adult population is typically around 7–8 hours per night; both very short and very long sleep show associations with higher risks.
• Plausible biological mechanisms include blood pressure alterations, inflammation, metabolic dysfunction, and variations in autonomic tone.
• Associations do not always imply causality: confounding factors and underlying diseases can influence the results.
• For persistent sleep problems, consult a doctor: some conditions (e.g., obstructive sleep apnea) are diagnosable and treatable.

Limitations of the evidence

The most relevant distinction is between observational studies and causal evidence from randomized controlled trials. Most of the evidence on sleep and CVD comes from prospective cohorts and meta-analyses; these can establish associations but cannot confirm that modifying sleep directly changes cardiovascular risk in all circumstances [2][3][5].

Recurring methodological limitations: subjective sleep measurement (self-reporting), variability in definitions of “sufficient sleep,” possible residual confounding (socioeconomic status, undiagnosed comorbidities), and risk of reverse causality (underlying disease altering sleep). Furthermore, the presence of sleep-disordered breathing can mask or modify observed associations [4][6][8].

To translate associations into clinical recommendations, well-designed intervention studies are needed to evaluate whether improving sleep duration or quality reduces long-term cardiovascular outcomes; currently, such evidence is limited.

Editorial conclusion

The knowledge accumulated in recent years converges on a prudent message: sleep is a relevant element for cardiovascular health at the population level. The observed associations, consistent with plausible biological mechanisms, justify the inclusion of sleep in primary prevention strategies as a factor to consider along with diet, physical activity, and control of cardiometabolic factors. However, interpretation must remain cautious: much of the evidence is observational and does not replace individual clinical evaluation. For persistent sleep problems or for those with cardiovascular conditions, consultation with a doctor is the correct way to define diagnosis and possible therapeutic pathways.

Editorial note

Text updated based on available reviews and scientific evidence. The article is for informational purposes and is not intended to provide diagnoses or prescriptions.

SCIENTIFIC RESEARCH

1. Hoevenaar-Blom MP, Spijkerman AMW, Kromhout D, Verschuren WMM. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study. Eur J Prev Cardiol. 2014 Nov;21(11):1367–1375. https://doi.org/10.1177/2047487313493057
2. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–1492. https://doi.org/10.1093/eurheartj/ehr007
3. Kwok CS, Kontopantelis E, Kuligowski G, et al. Self-reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis. J Am Heart Assoc. 2018;7(15):e008552. https://doi.org/10.1161/JAHA.118.008552
4. Wang Y, Wang J, Chen S, et al. Association of longitudinal patterns of habitual sleep duration with risk of cardiovascular events and all-cause mortality. JAMA Netw Open. 2020;3(5):e205246. https://doi.org/10.1001/jamanetworkopen.2020.5246
5. Huang Y-M, Xia W, Ge Y-J, et al. Sleep duration and risk of cardio‑cerebrovascular disease: a dose‑response meta‑analysis of cohort studies comprising 3.8 million participants. Front Cardiovasc Med. 2022;9:907990. https://doi.org/10.3389/fcvm.2022.907990
6. Wang C, Bangdiwala SI, Rangarajan S, et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116,632 people from 21 countries. Eur Heart J. 2019;40(20):1620–1629. https://doi.org/10.1093/eurheartj/ehy695
7. Domínguez F, Fuster V, Fernández‑Alvira JM, et al. Association of sleep duration and quality with subclinical atherosclerosis. J Am Coll Cardiol. 2019;73(2):134–144. https://doi.org/10.1016/j.jacc.2018.10.060
8. St‑Onge MP, Grandner MA, Brown D, et al.; American Heart Association. Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health — a scientific statement from the American Heart Association. Circulation. 2016;134(18):e367–e386. https://doi.org/10.1161/CIR.0000000000000444
9. Mullington JM, Haack M, Toth M, Serrador JM, Meier‑Ewert HK. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis. 2009;51(4):294–302. https://doi.org/10.1016/j.pcad.2008.10.003